Annual Cash & Cash Equivalents
$7.57 M
-$5.81 M-43.42%
31 December 2023
Summary:
Cyclerion Therapeutics annual cash & cash equivalents is currently $7.57 million, with the most recent change of -$5.81 million (-43.42%) on 31 December 2023. During the last 3 years, it has fallen by -$46.82 million (-86.08%). CYCN annual cash & cash equivalents is now -92.02% below its all-time high of $94.89 million, reached on 31 December 2019.CYCN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$2.87 M
-$1.72 M-37.40%
30 September 2024
Summary:
Cyclerion Therapeutics quarterly cash and cash equivalents is currently $2.87 million, with the most recent change of -$1.72 million (-37.40%) on 30 September 2024. Over the past year, it has dropped by -$6.24 million (-68.47%). CYCN quarterly cash and cash equivalents is now -97.96% below its all-time high of $141.03 million, reached on 30 June 2019.CYCN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYCN Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.4% | -68.5% |
| 3 y3 years | -86.1% | -95.4% |
| 5 y5 years | +100.0% | -97.5% |
CYCN Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -86.1% | at low | -95.4% | at low |
| 5 y | 5 years | -92.0% | -97.5% | at low | |
| alltime | all time | -92.0% | -98.0% |
Cyclerion Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.87 M(-37.4%) |
| June 2024 | - | $4.59 M(-19.5%) |
| Mar 2024 | - | $5.70 M(-24.8%) |
| Dec 2023 | $7.57 M(-43.4%) | $7.57 M(-16.9%) |
| Sept 2023 | - | $9.11 M(+61.5%) |
| June 2023 | - | $5.64 M(-21.3%) |
| Mar 2023 | - | $7.17 M(-46.4%) |
| Dec 2022 | $13.38 M(-75.2%) | $13.38 M(-34.4%) |
| Sept 2022 | - | $20.41 M(-32.7%) |
| June 2022 | - | $30.32 M(-26.3%) |
| Mar 2022 | - | $41.13 M(-23.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $53.96 M(-0.8%) | $53.96 M(-13.7%) |
| Sept 2021 | - | $62.50 M(-11.2%) |
| June 2021 | - | $70.39 M(+69.9%) |
| Mar 2021 | - | $41.43 M(-23.8%) |
| Dec 2020 | $54.40 M(-42.7%) | $54.40 M(-18.6%) |
| Sept 2020 | - | $66.84 M(+18.4%) |
| June 2020 | - | $56.46 M(-15.8%) |
| Mar 2020 | - | $67.10 M(-29.3%) |
| Dec 2019 | $94.89 M(>+9900.0%) | $94.89 M(-18.9%) |
| Sept 2019 | - | $117.03 M(-17.0%) |
| June 2019 | - | $141.03 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Cyclerion Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics annual cash & cash equivalents year-on-year change?
- What is Cyclerion Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Cyclerion Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CYCN is $7.57 M
What is the all time high annual cash & cash equivalents for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high annual cash & cash equivalents is $94.89 M
What is Cyclerion Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, CYCN annual cash & cash equivalents has changed by -$5.81 M (-43.42%)
What is Cyclerion Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CYCN is $2.87 M
What is the all time high quarterly cash and cash equivalents for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high quarterly cash and cash equivalents is $141.03 M
What is Cyclerion Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, CYCN quarterly cash and cash equivalents has changed by -$6.24 M (-68.47%)